Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk
Cardiovascular Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/cdr/6340671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 11.05.2026. Verfasst von Yanbing Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China, gxmu.edu.cn. Hauptthemen laut MEDLINE: Heart Failure, Cytokines, Inflammation Mediators, Polymorphism, Single Nucleotide. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Central Government Guides Local Science and Technology Development Funding Projects, Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure (HF) is a critical condition characterized by the heart′s inability to pump blood effectively, leading to significant morbidity and mortality. Inflammation and metabolic disturbances play key roles in its progression. This study is aimed at elucidating the causal relationships between inflammatory cytokines, metabolites, and HF using Mendelian randomization (MR).
Methods
A three‐step, two‐sample MR analysis was performed using genetic data from genome‐wide association studies. The study included data on 91 inflammatory cytokines, over 1400 metabolites, and HF cases from the FinnGen project, comprising 29,672 cases and 382,509 controls. Single‐nucleotide polymorphisms with significant associations ( p < 1 × 10 −5 ) were selected as instrumental variables. The inverse variance–weighted method was the primary analytical tool, supplemented by MR‐Egger, weighted median, simple mode, and weighted mode methods. Heterogeneity was assessed with Cochran′s Q test, and pleiotropy was evaluated using MR‐Egger intercept and MR‐PRESSO. Robustness was confirmed through leave‐one‐out sensitivity analysis.
Results
The MR analysis identified eight inflammatory cytokines significantly associated with HF risk. Elevated levels of three cytokines (FGF19, MMP‐1, and TNF‐ β ) were linked to an increased risk of HF, whereas five cytokines (DNER, IL‐10, uPA, TNFSF12, and LIFR) were linked to a decreased risk of HF. Additionally, 12 metabolites were found to be significantly associated with HF, with 6 (2PY, BCG, NAG/NAGal, X‐24801, X‐21283, and X‐22776) enhancing risk and 6 (PC, 3HL, 2‐BG, X‐23659, X‐25422, and X‐24546) showing protective effects. Notably, mediation analysis indicated that certain metabolites, X‐22776, mediated the effect of uPA on HF.
Conclusions
This study provides novel genetic evidence supporting the causal role of inflammatory cytokines in HF and highlights the mediating role of metabolites. These findings offer new insights into the pathogenesis of HF and suggest potential biomarkers and therapeutic targets for its prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China, gxmu.edu.cn.
- Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, Nanning, Guangxi, China, gxmu.edu.cn.
- Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, Nanning, Guangxi, China, gxmu.edu.cn.
- School of Nursing, Guangxi Medical University, Nanning, Guangxi, China, gxmu.edu.cn.
- Department of Bone and Joint Surgery (Guangxi Diabetic Foot Salvage Engineering Research Center/Research Centre for Regenerative Medicine), The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi,…
ORCID-Profile: Peilin Zhou, Feng Huang, Zhiyu Zeng
Förderung
- The Central Government Guides Local Science and Technology Development Funding Projects
- Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention
Zitieren
APA
Yao, Y., Tang, L., Zhou, P., Huang, F., & Zeng, Z. (2026). Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/6340671
Vancouver
Yao Y, Tang L, Zhou P, Huang F, Zeng Z. Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/6340671
BibTeX
@article{Yao2026,
author = {Yao, Yanbing and Tang, Linghui and Zhou, Peilin and Huang, Feng and Zeng, Zhiyu},
title = {Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk},
journal = {Cardiovascular Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cdr/6340671}
}
EUVIMED